Cancer/Tumor Profiling Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW
:
Tumor profiling services use a variety of methods for the examination of patient's tumor. Some utilize next generation DNA sequencing or RNA sequencing, while others analyze protein expression. Multiple technologies are used to provide very specific information about the molecular and genetic makeup of the tumor. Tumor profiling companies utilize various methods to examine the biopsy sample, and return information about the genes altered in the cancer cells.

MARKET SCOPE

The "Cancer/tumor profiling market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cancer/tumor profiling market with detailed market segmentation by of Product, Technology, Animal type, End Users. The cancer/tumor profiling market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cancer/tumor profiling market and offers key trends and opportunities in the market.
MARKET SEGMENTATION

•  n the basis of product, the market is segmented into Instruments and Consumables.
  
•  n the basis of technology, the market is segmented into Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis and Others.
  
•  n the basis of animal type, the market is segmented into Livestock animals, Companion, Animal.
  
•  n the basis of end User, the market is segmented into Veterinary Hospitals and Clinics, Homecare Settings, Reference Laboratories and Research Institutes & Universities.
  

MARKET DYNAMICS
Drivers:

•  Oncologists are increasingly using cancer profiling methods to diagnose and treat malignancies, as well as predict response to targeted therapy. Furthermore, an increase in the use of cancer biomarkers for tumour profiling, an increase in cancer incidence around the world, and an increase in the use of next-generation sequencing techniques for cancer profiling all contribute to the market's growth.
  

Restraints

The market's growth is hampered by high monetary investments in biomarker research and a shortage of experienced specialists or oncologists that specialized in tumor profiling.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cancer/tumor profiling market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer/tumor profiling market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cancer/tumor profiling market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the cancer/tumor profiling market in these regions.

IMPACT OF COVID-19 ON CANCER/TUMOR PROFILING MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the cancer/tumor profiling market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Cancer/Tumor Profiling Market Report Analysis

Cancer/Tumor Profiling Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Illumina, Inc.
• QIAGEN N.V.
• NeoGenomics Laboratories, Inc.
• HTG Molecular Diagnostics, Inc.
• Genomic Health Inc.
• Caris Life Sciences
• Helomics Corporation
• NanoString Technologies, Inc.
• Sysmex Corporation

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Technology

• Immunoassays
• Hybridization
• Sequencing Techniques
• Mass Spectrometry

By Cancer Type

• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma Cancer

By Application

• Clinical Application and Research Application

MARKET PLAYERS

The report covers key developments in the cancer/tumor profiling market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cancer/tumor profiling market are anticipated to have lucrative growth opportunities in the future with the rising demand for cancer/tumor profiling market in the global market. Below mentioned is the list of few companies engaged in the cancer/tumor profiling market.

The report also includes the profiles of key players in cancer/tumor profiling market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

•  Illumina, Inc.
  
•  QIAGEN N.V.
  
•  NeoGenomics Laboratories, Inc.
  
•  HTG Molecular Diagnostics, Inc.
  
•  Genomic Health Inc.
  
•  Caris Life Sciences
  
•  Helomics Corporation
  
•  NanoString Technologies, Inc.
  
•  Sysmex Corporation
  
•  Roche Diagnostics
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Cancer/Tumor Profiling Market Report Scope